Clinical evaluation of seven tumour markers in lung cancer ... | 合法醫療器材資訊網

Read More

由 J Niklinski 著作 · 1995 · 被引用 137 次 — CEA, TPA, SCC-Ag, CYFRA 21-1, ferritin, CA19-9, CA50, CA242, H-K-N-ras mutations and p53 mutation seem to be the most prolific in NSCLC, while NSE, BN/GRP, CK- ... Read More

由 K Sugio 著作 · 2004 · 被引用 13 次 — In small cell lung cancer, NSE and proGRP are effective markers. In non-small cell lung cancer (NSCLC), CEA, SCC, CYFRA21-1, SLX and CA19-9 are commonly used ... Read More

由 V Macchia 著作 · 1987 · 被引用 26 次 — Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin · Authors · Affiliation. Read More

由 M Grunnet 著作 · 2012 · 被引用 495 次 — No studies found CEA levels useful as a diagnostic marker for lung cancer. With regard to NSCLC the level of CEA measured in tumor tissue in ... Read More

由 KD Hatzakis 著作 · 2002 · 被引用 172 次 — From the 84 patients with NSCLC, 34 patients (33%) had squamous-cell lung cancer, 23 (22%) adenocarcinoma and 23 (22%) large-cell carcinomas. The overall median ... Read More

由 M Plebani 著作 · 1995 · 被引用 127 次 — In this study we compared the diagnostic utility of: (1) neuron-specific enolase (NSE); (2) squamous cell carcinoma antigen (SCC); (3) carcinoembryonic ... Read More

由 M Hansen 著作 · 1986 · 被引用 54 次 — The most examined tumor markers in lung cancer patients are CEA, hormonal peptides, and some neurogenic enzymes in small cell carcinoma. Read More

Tests for lung cancer tumor markers are most often used to find out which, if any, genetic mutation is causing your lung cancer. Lung cancer markers may be ... Read More